New Lobular Breast Cancer Program at Memorial Sloan Kettering: Interview with the Co-Directors скачать в хорошем качестве

New Lobular Breast Cancer Program at Memorial Sloan Kettering: Interview with the Co-Directors

This year Memorial Sloan Kettering launched a new Lobular Breast Cancer Program! This new program, one of the first three in the world to launch at a major cancer center, focuses on improving treatment for patients with lobular breast cancer and increasing important ILC research. In this interview with the program's three co-directors, breast medical oncologist Dr. Sherry Shen, breast surgeon, Dr. Anita Mamtani and LBCA Scientific Advisory Board member and breast pathologist Dr. Fresia Pareja, they discuss the vision for the new program and what is already happening. Plans include more collaboration among other new breast cancer programs that will focus on lobular breast cancer and with lobular researchers around the world to accelerate ILC research. In addition, new breast cancer clinical trials that focus specifically on or at least are enriched for lobular breast cancer are being formed.